Literature DB >> 29956143

Induction and Characterization of the Allergic Eye Disease Mouse Model.

Nancy J Reyes1, Rose Mathew1, Daniel R Saban2,3.   

Abstract

Ocular IgE-associated allergy ranges from mild disease (seasonal and perennial allergic conjunctivitis) to more chronic/severe and vision-threatening forms (atopic and vernal keratoconjunctivitis). Whereas mild forms of disease have been studied extensively, less is known about the more chronic forms. Our lab has helped to address this knowledge gap by developing and characterizing an allergen-induced, chronic/severe, IgE-associated model of ocular allergy referred to as the severe allergic eye disease (AED) model. It is distinct from previously described models that mimic the more mild forms, referred to in the literature as the allergic conjunctivitis (AC) model. The purpose of this method article is to detail the protocol to induce and characterize the AED model and directly compare these mice to the mild AC model. Troubleshooting and implications are also discussed.

Entities:  

Keywords:  AED; Allergic conjunctivitis; Allergic eye disease; Allergy; Conjunctivitis; Dendritic cells; Fibrosis; T cells; Th2; Type 2 immunity

Mesh:

Substances:

Year:  2018        PMID: 29956143     DOI: 10.1007/978-1-4939-7896-0_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Meibomian gland dysfunction is suppressed via selective inhibition of immune responses by topical LFA-1/ICAM antagonism with lifitegrast in the allergic eye disease (AED) model.

Authors:  Pali P Singh; Chen Yu; Rose Mathew; Victor L Perez; Daniel R Saban
Journal:  Ocul Surf       Date:  2021-03-31       Impact factor: 6.268

2.  Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells.

Authors:  Malihe Eskandarpour; Xiaozhe Zhang; Alessandra Micera; Sarah Zaher; Frank D P Larkin; Miles Nunn; Stefano Bonini; Wynne Weston-Davies; Virginia L Calder
Journal:  Allergy       Date:  2021-10-15       Impact factor: 14.710

3.  Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde Dehydrogenase.

Authors:  Sabrina Patzelt; Manuela Pigors; Heiko Steenbock; Leonard Diel; Katharina Boch; Lenche Chakievska; Sven Künzel; Hauke Busch; Anke Fähnrich; Jürgen Brinckmann; Enno Schmidt
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

4.  Knowledge and awareness of ocular allergy among Jeddah population.

Authors:  Muaz S Bazuhair; Hamzah H Alsabban; Kasim H Alsabban; Khalid A Alzahrani; Ali A Alattas; Abdullah M Khinkar; Emad M Salawati
Journal:  J Family Med Prim Care       Date:  2022-03-18

5.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Authors:  Daniel Wolff; Vedran Radojcic; Robert Lafyatis; Resat Cinar; Rachel K Rosenstein; Edward W Cowen; Guang-Shing Cheng; Ajay Sheshadri; Anne Bergeron; Kirsten M Williams; Jamie L Todd; Takanori Teshima; Geoffrey D E Cuvelier; Ernst Holler; Shannon R McCurdy; Robert R Jenq; Alan M Hanash; David Jacobsohn; Bianca D Santomasso; Sandeep Jain; Yoko Ogawa; Philipp Steven; Zhonghui Katie Luo; Tina Dietrich-Ntoukas; Daniel Saban; Ervina Bilic; Olaf Penack; Linda M Griffith; Meredith Cowden; Paul J Martin; Hildegard T Greinix; Stefanie Sarantopoulos; Gerard Socie; Bruce R Blazar; Joseph Pidala; Carrie L Kitko; Daniel R Couriel; Corey Cutler; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Sophie Paczesny
Journal:  Transplant Cell Ther       Date:  2021-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.